Recent challenges in cardiology include the rapid integration of digital health technologies, which, while offering opportunities for remote monitoring and personalized care, also present challenges related to data security, interoperability, and the ethical use of patient information. The emergence of novel cardiovascular therapeutics, including gene and cell-based therapies, brings new possibilities for treatment but poses challenges in terms of regulatory frameworks, long-term safety assessments, and equitable access. Another challenge is the impact of environmental factors on cardiovascular health, with air pollution, climate change, and urbanization influencing the prevalence and severity of cardiovascular diseases. The dynamic nature of infectious diseases, as exemplified by the COVID-19 pandemic, also presents challenges in understanding the long-term cardiovascular consequences of viral infections. Navigating these challenges requires ongoing collaboration among clinicians, researchers, policymakers, and technology developers to develop comprehensive and adaptable strategies for addressing the multifaceted aspects of cardiovascular health in an ever-changing global context.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China